Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthropathies: A reassessment

Rheumatology

Volumn 47, Issue 2, 2008, Pages 142-144

  Aydin, S Z ^a   Atagunduz, Pamirat ^a   Temel, M ^a   Bicakcigil, M ^a   Tasan, D ^a   Direskeneli, H ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

ASCA; Radiographic assessment; Severity; Spondyloarthropathies

Indexed keywords

BACTERIUM ANTIBODY; C REACTIVE PROTEIN; IMMUNOGLOBULIN A; SACCHAROMYCES CEREVISIAE ANTIBODY; TUMOR NECROSIS FACTOR DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BATH ANKYLOSING SPONDYLITIS FUNCTIONAL INDEX; CONTROLLED STUDY; CROHN DISEASE; DEMOGRAPHY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; IMAGE DISPLAY; MAJOR CLINICAL STUDY; MALE; MODIFIED STROKE ANKYLOSING SPONDYLITIS SPINAL SCORE; NONHUMAN; PRIORITY JOURNAL; RADIODIAGNOSIS; SCORING SYSTEM; SEROPREVALENCE; SPONDYLOARTHROPATHY;

ANTIBODIES, FUNGAL; DISEASE PROGRESSION; HLA-B27 ANTIGEN; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; REFERENCE VALUES; SACCHAROMYCES CEREVISIAE; SPONDYLARTHRITIS;

EID: 38649104458     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem324     Document Type: Article

References (23)

1. Meuwissen SG, Dekker-Saeys BJ, Agenant D, Tytgat GN. Ankylosing spondylitis and inflammatory bowel disease. I. Prevalence of Inflammatory bowel disease in patients suffering from ankylosing spondylitis. Am Rheum Dis 1978;37:30-2.
2. De Vos M, Cuvelier C, Mielants H, Veys E, Barbier F, Elewaut A. Ileocolonoscopy in seronegative spondylarthropathy. Gastroenterology 1989:96:339-44.
3. Mielants H, Veys EM, Cuvelier C, do Vos M. lleocelonoscopic findings in seronegative spondylarthropathies. Br J Rheumatol 1988;27(Suppl. 2):95-105.
4. Leirisalo-Repo M, Turunen U, Stenman S, Melenius P, Seppala K. High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum 1994;37:23-31.
5. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: A study of 700 patients. Medicine 1976;55:401-12.
6. Palm O, Moum B, Johnson J, Gran JT. The prevalence and incidence of peripheral arthritis in petients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). Rheumatology 2001;40:1256-61.
7. Quinton JF, Sendid B, Reumaux D et al. Anti-Saccharomyces carevisiae mannan antibodies combined with antinoutrophil cytoplasmic; autoantibodies in inflammatory bowel disease: Prevalence and diagnostic role. Gut 1998;42:788-91.
8. Vermeire S, Joossens S, Peeters M et al. Comparative study of ASCA (Anti-Saccharomyces oerevisiae antibody) assays in Inflammatory bowel disease. Gastroenterology 2001:120:827-33.
9. Linskens RK, Mallant-Hent RC, Groothuisimink ZM et al. Evaluation of serological markers to differentiate between ulcerative oolitis and Crohn's disease: PANCA, ASCA and agglutinatirg antibodies to anaerobic coccoid rods. Eur J Gastroenterol Hepatol 2002;14:1013-8.
10. Joossens S, Reinisch W, Vermaire S et al. The value of serologic markers in indeterminate colitis: A prospective follow-up study. Gastroenterology 2002;122:1242-7.
11. Hoffman IE A. Demetter P, Peeters M et al. Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy. Ann Rheum Dis 2003;62:455-9.
12. Tōrök HP, Olas J, Gruber R et al. Inflammatory bowel disease-specific autoati-bodies in HLA-B27-associatad spondyloarthropathies: Increased prevalence of ASCA and pANCA-Digestion 2004;70:49-54.
13. Riente L, Chimenti D, Pratesi F et al. Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis. J Rhoumatol 2004;31:920-4.
14. Colin A, Nakache JP, Gueguen A, Zeldler H, Mielants H, Dougados M. Defining disease activity in ankylosing spondylitis: Is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology 1999;38:57842.
15. Fernandez-Sueiro JL, Pinto JA, López-Armada, MJ, Pértega S, Galdo F, Blanco FJ. Anti-Sachccaromyces cerevisiae antibodies and disease activity in ankylosing spondylitis: Clinical correlations. Ann Rheum Dis 2006;65(Suppl 11):216.
16. Fernández-Sueiro JL, Willisch A, López-Armada M et al. HLA-B27 does not influence the presence of Anti-Saccharomyces cerevisiae antibodies in a population of ankylosing spondylitis patients from the northwest part of Spain. Ann Rheum Dis 2005;64(Suppl. III):331.
17. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
18. Dougados M, van der Linden S, Junlin R et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
19. Barta Z, Csipo I, Szabo GG, Szegedi G. Seroreactivity against Saccharomyces cerevisiae pedients with Crohn's disease and celiac disease. World J Gastroenterol 2003;9:2308-12.
20. Muratori P, Muratori L, Guidi M et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol 2003;132:473-6.
21. Condino AA, Hoffenberg EJ, Accurso F et al. Frequency of ASCA seropositivity in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 2005;41:23-6.
22. Fresko I, Ugurlu S, Ozbakir F et al. Anti-Saccharomyces carevisiae anti-bodies (ASCA) in Behcet's syndrome. Clin Exp Rheumatol 2005;23(4 Suppl. 38): S67-70.
23. Klebl FH, Bataille F, Hefstadter F, Herfarth H, Scholmerich J, Rogler G. Optimising the diagnostic value of anti-Saccharonmyces cerevisiae antibodies (ASCA) in Crohn's disease. Int J Colorectal Dis 2004:319-24.